PE20080261A1 - Sales y modificaciones del cristal de las mismas - Google Patents
Sales y modificaciones del cristal de las mismasInfo
- Publication number
- PE20080261A1 PE20080261A1 PE2007000619A PE2007000619A PE20080261A1 PE 20080261 A1 PE20080261 A1 PE 20080261A1 PE 2007000619 A PE2007000619 A PE 2007000619A PE 2007000619 A PE2007000619 A PE 2007000619A PE 20080261 A1 PE20080261 A1 PE 20080261A1
- Authority
- PE
- Peru
- Prior art keywords
- salt
- phenyl
- refers
- salts
- glass
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
- C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
- C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
- C07D243/24—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
SE REFIERE A UNA SAL DE MONOHIDRATO DE BESILATO DE 1-(2-FLUORO-FENIL)-3-(2-OXO-5-FENIL-2,3-DIHIDRO-1H-BENZO-[e]-[1,4]-DIAZEPIN-3-IL)-UREA CRISTALINO CARACTERIZADO POR UN PATRON DE RAYOS-X EN UN ANGULO DE DIFRACCION 2-THETA DE 7.5 +-0.5, 21.3+-0.5. SE REFIERE TAMBIEN A UN PROCEDIMIENTO DE PREPARACION DE DICHA SAL QUE COMPRENDE DE CRISTALIZAR O RECRISTALIZAR LA SAL DE BESILATO EN UNA SOLUCION QUE COMPRENDE ACETONA, ACETONICTRILO, ACETATO DE ETILO O TERBUTIL-METIL-ETER
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US80283606P | 2006-05-23 | 2006-05-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20080261A1 true PE20080261A1 (es) | 2008-04-18 |
Family
ID=38704747
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2007000619A PE20080261A1 (es) | 2006-05-23 | 2007-05-21 | Sales y modificaciones del cristal de las mismas |
Country Status (28)
Country | Link |
---|---|
US (1) | US7977330B2 (es) |
EP (1) | EP2029556B1 (es) |
JP (2) | JP2009538330A (es) |
KR (1) | KR20090009898A (es) |
CN (1) | CN101448796B (es) |
AR (1) | AR061056A1 (es) |
AT (1) | ATE486858T1 (es) |
AU (1) | AU2007267671A1 (es) |
BR (1) | BRPI0712556A2 (es) |
CA (1) | CA2650514A1 (es) |
CL (1) | CL2007001454A1 (es) |
CR (1) | CR10431A (es) |
DE (1) | DE602007010286D1 (es) |
EC (1) | ECSP088900A (es) |
ES (1) | ES2355166T3 (es) |
GT (1) | GT200800253A (es) |
IL (1) | IL195008A0 (es) |
MA (1) | MA30482B1 (es) |
MX (1) | MX2008014836A (es) |
NO (1) | NO20085000L (es) |
PE (1) | PE20080261A1 (es) |
PL (1) | PL2029556T3 (es) |
PT (1) | PT2029556E (es) |
RU (1) | RU2008150627A (es) |
TN (1) | TNSN08477A1 (es) |
TW (1) | TW200815375A (es) |
WO (1) | WO2007140154A2 (es) |
ZA (1) | ZA200809096B (es) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MXPA05002871A (es) | 2002-09-20 | 2005-10-05 | Arrow Therapeutics Ltd | Derivados de benzodiazaepina y composiciones farmaceuticas que los contienen. |
-
2007
- 2007-05-21 PE PE2007000619A patent/PE20080261A1/es not_active Application Discontinuation
- 2007-05-21 JP JP2009512241A patent/JP2009538330A/ja active Pending
- 2007-05-21 MX MX2008014836A patent/MX2008014836A/es not_active Application Discontinuation
- 2007-05-21 EP EP07797606A patent/EP2029556B1/en active Active
- 2007-05-21 CN CN2007800181255A patent/CN101448796B/zh not_active Expired - Fee Related
- 2007-05-21 WO PCT/US2007/069327 patent/WO2007140154A2/en active Application Filing
- 2007-05-21 AR ARP070102191A patent/AR061056A1/es unknown
- 2007-05-21 KR KR1020087028592A patent/KR20090009898A/ko not_active Application Discontinuation
- 2007-05-21 US US12/298,203 patent/US7977330B2/en not_active Expired - Fee Related
- 2007-05-21 CA CA002650514A patent/CA2650514A1/en not_active Abandoned
- 2007-05-21 AU AU2007267671A patent/AU2007267671A1/en not_active Abandoned
- 2007-05-21 BR BRPI0712556-9A patent/BRPI0712556A2/pt not_active Application Discontinuation
- 2007-05-21 AT AT07797606T patent/ATE486858T1/de active
- 2007-05-21 DE DE602007010286T patent/DE602007010286D1/de active Active
- 2007-05-21 ES ES07797606T patent/ES2355166T3/es active Active
- 2007-05-21 PL PL07797606T patent/PL2029556T3/pl unknown
- 2007-05-21 PT PT07797606T patent/PT2029556E/pt unknown
- 2007-05-21 RU RU2008150627/04A patent/RU2008150627A/ru not_active Application Discontinuation
- 2007-05-22 TW TW096118228A patent/TW200815375A/zh unknown
- 2007-05-22 CL CL200701454A patent/CL2007001454A1/es unknown
-
2008
- 2008-10-23 ZA ZA200809096A patent/ZA200809096B/xx unknown
- 2008-10-30 IL IL195008A patent/IL195008A0/en unknown
- 2008-11-10 CR CR10431A patent/CR10431A/es not_active Application Discontinuation
- 2008-11-21 GT GT200800253A patent/GT200800253A/es unknown
- 2008-11-21 TN TNP2008000477A patent/TNSN08477A1/en unknown
- 2008-11-21 EC EC2008008900A patent/ECSP088900A/es unknown
- 2008-11-26 MA MA31419A patent/MA30482B1/fr unknown
- 2008-11-28 NO NO20085000A patent/NO20085000L/no not_active Application Discontinuation
-
2013
- 2013-01-04 JP JP2013000196A patent/JP2013075910A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
CR10431A (es) | 2009-01-07 |
US20090163478A1 (en) | 2009-06-25 |
US7977330B2 (en) | 2011-07-12 |
WO2007140154A2 (en) | 2007-12-06 |
MX2008014836A (es) | 2008-12-01 |
ECSP088900A (es) | 2008-12-30 |
IL195008A0 (en) | 2009-08-03 |
EP2029556B1 (en) | 2010-11-03 |
MA30482B1 (fr) | 2009-06-01 |
AR061056A1 (es) | 2008-07-30 |
PL2029556T3 (pl) | 2011-04-29 |
CL2007001454A1 (es) | 2008-05-16 |
RU2008150627A (ru) | 2010-06-27 |
BRPI0712556A2 (pt) | 2013-07-02 |
JP2013075910A (ja) | 2013-04-25 |
KR20090009898A (ko) | 2009-01-23 |
ATE486858T1 (de) | 2010-11-15 |
AU2007267671A1 (en) | 2007-12-06 |
TNSN08477A1 (en) | 2010-04-14 |
JP2009538330A (ja) | 2009-11-05 |
DE602007010286D1 (de) | 2010-12-16 |
ES2355166T3 (es) | 2011-03-23 |
PT2029556E (pt) | 2011-01-31 |
CN101448796B (zh) | 2012-09-26 |
TW200815375A (en) | 2008-04-01 |
GT200800253A (es) | 2009-04-29 |
NO20085000L (no) | 2008-12-23 |
WO2007140154A3 (en) | 2008-03-20 |
EP2029556A2 (en) | 2009-03-04 |
ZA200809096B (en) | 2009-11-25 |
CN101448796A (zh) | 2009-06-03 |
CA2650514A1 (en) | 2007-12-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR114946A2 (es) | Formas cristalinas de 3-(2,6-dicloro-3,5-dimetoxi-fenil)-1-{6-[4-(4-etil-piperazin-1-il)-fenil-amino]-pirimidin-4-il}-1-metil-urea y sales de las mismas | |
AR116431A2 (es) | Procesos e intermediarios para preparar un inhibidor de jak | |
PE20120083A1 (es) | Sal monotosilato del compuesto 2-metil-2-[4-(3-metil-2-oxo-8-quinolin-3-il-2, 3-dihidro-imidazo-[4,5-c]-quinolin-1-il)-fenil]-propionitrilo en su forma cristalina a | |
UY30408A1 (es) | Derivados sustituidos del acetato de 8-(4-metoxifenil)-2,3,4,8-tetrahidroimidazo-[1,5-a]-pirimidin-6-amina, composiciones farmacéuticas y aplicaciones | |
AR061980A1 (es) | Acilanilidas sustituidas y metodos para su utilizacion | |
EA201200669A1 (ru) | ПИРИДОПИРИМИДИНОНОВЫЕ ИНГИБИТОРЫ PI3Kα | |
EA200800760A1 (ru) | ПИРИДОПИРИМИДИНОНОВЫЕ ИНГИБИТОРЫ PI3Kα | |
PE20081258A1 (es) | ANTICUERPOS ANTI-hTNFALFA CRISTALINOS | |
PA8680701A1 (es) | Derivados de oxindol | |
ECSP034436A (es) | Sales de valsartan | |
BR112014013974A8 (pt) | derivados de sulfonamida benzílicos como moduladores de rorc | |
UY28902A1 (es) | Derivados de piridazinona, métodos para producirlos y su uso como productos farmacéuticos | |
ECSP078030A (es) | Formas cristalinas y otras formas de las sales de ácido láctico de 4-amino-5-fluoro-3-[6-(4-metilpiperazin -1-il)-1h-bencimidazol-2 -il]-1h-quinolin-2-ona | |
NO20085099L (no) | Puritonderivativer som HM74A agonister | |
NO20053099D0 (no) | Fremgangsmate for a fremstille optisk rene aktive forbindelser. | |
UY29616A1 (es) | Compuestos químicos iii | |
NO20053687D0 (no) | Crystallisation Process. | |
CO6480931A2 (es) | Sulfonamidas heterocíclicas, usos y composiciones farmacéuticas de las mismas. | |
AR051796A1 (es) | Derivados de hidantoina como inhibidores de metaloproteinasas | |
ECSP088700A (es) | Acidos 4-fenil-tiazol-5-carboxilicos y amidas de acidos 4-fenil-tiazol-5-carboxilicos como inhibidores de la plk1 | |
DK1856063T3 (da) | 5-phenyl-pentansyrederivater som matrix- metalloproteinaseinhibitorer til behandlingen af astma og andre sygdomme | |
AR068438A1 (es) | Derivado de 6-pirimidinil-pirimid-2-ona | |
MX2009012376A (es) | Derivados de pirimidona sustituidos con heteroarilamida para el tratamiento de enfermedades neurodegenerativas. | |
DOP2009000130A (es) | Sal de potasio cristalina de analogos de lipoxina a4 | |
BR112014008783A2 (pt) | compostos para o tratamento e profilaxia da doença causada por vírus sincicial respiratório |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Refusal |